by admin_prosemble | 17th March 2025 | News, Research
A nice summary of our discovery, and how we are using it at Prosemble, from our “parent” institution, King’s College London: Newly identified bacterial protein to help with design of cancer drug delivery system | King’s College...
by admin_prosemble | 4th March 2025 | News, Research
The peer-reviewed version of our paper reporting the structure of our tubular nanoparticles, is now out in PNAS! https://www.pnas.org/doi/10.1073/pnas.2500913122
by admin_prosemble | 24th January 2025 | News, Research
Prosemble proudly announces that its initial angel investor funding round has been oversubscribed. This strong support underscores confidence in our mission to transform precision therapies.
by admin_prosemble | 13th January 2025 | News, Research
Prosemble begins Immunogenicity/Tox Studies, including Toxicity Study in NCG immunodeficient mice, in collaboration with TransCure BioServices. Exciting progress ahead! transcurebioservices.com
by admin_prosemble | 11th December 2024 | News, Research
The cytoskeleton is essential for cell organisation and movement, with actin filaments in eukaryotes and actin-like proteins in bacteria playing key roles. This study identifies a novel bacterial actin family in the Verrucomicrobiota phylum, forming unique...
by admin_prosemble | 9th November 2024 | Research, Uncategorized
The cytoskeleton is vital for cell organisation and movement. While eukaryotic actin forms conserved double-stranded filaments, bacterial actins drive key functions and exhibit diverse architectures. We identify a novel actin family in Verrucomicrobiota, forming...
